End-of-day quote
Shanghai S.E.
23:00:00 13/05/2024 BST
|
5-day change
|
1st Jan Change
|
18.19
CNY
|
+0.94%
|
|
-5.51%
|
-27.15%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,452
|
2,844
|
2,053
|
2,336
|
Enterprise Value (EV)
1 |
2,606
|
2,219
|
1,812
|
2,245
|
P/E ratio
|
33.9
x
|
35.8
x
|
48.9
x
|
59.5
x
|
Yield
|
0.76%
|
0.89%
|
0.64%
|
-
|
Capitalization / Revenue
|
9.19
x
|
6.48
x
|
4.05
x
|
4.7
x
|
EV / Revenue
|
6.94
x
|
5.06
x
|
3.57
x
|
4.51
x
|
EV / EBITDA
|
29.6
x
|
29.6
x
|
33.5
x
|
38.5
x
|
EV / FCF
|
454
x
|
-18.1
x
|
-26.4
x
|
-21.1
x
|
FCF Yield
|
0.22%
|
-5.52%
|
-3.79%
|
-4.74%
|
Price to Book
|
2.96
x
|
2.36
x
|
1.67
x
|
1.85
x
|
Nbr of stocks (in thousands)
|
93,340
|
93,340
|
93,340
|
93,568
|
Reference price
2 |
36.98
|
30.47
|
22.00
|
24.97
|
Announcement Date
|
13/04/21
|
01/04/22
|
20/04/23
|
22/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
306.3
|
355.2
|
375.4
|
439
|
507.4
|
497.3
|
EBITDA
1 |
83.26
|
94.73
|
88
|
75.04
|
54.14
|
58.37
|
EBIT
1 |
70.87
|
83.4
|
77.89
|
58.8
|
22.74
|
20.17
|
Operating Margin
|
23.14%
|
23.48%
|
20.75%
|
13.39%
|
4.48%
|
4.06%
|
Earnings before Tax (EBT)
1 |
74.47
|
87.25
|
99.85
|
88.72
|
28.79
|
16.85
|
Net income
1 |
61.47
|
73.99
|
84.75
|
79.78
|
42.69
|
40.06
|
Net margin
|
20.07%
|
20.83%
|
22.57%
|
18.17%
|
8.41%
|
8.06%
|
EPS
2 |
0.8800
|
1.060
|
1.090
|
0.8500
|
0.4500
|
0.4200
|
Free Cash Flow
1 |
10.45
|
33.78
|
5.743
|
-122.6
|
-68.66
|
-106.4
|
FCF margin
|
3.41%
|
9.51%
|
1.53%
|
-27.92%
|
-13.53%
|
-21.39%
|
FCF Conversion (EBITDA)
|
12.55%
|
35.66%
|
6.53%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
17%
|
45.66%
|
6.78%
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
0.2800
|
0.2700
|
0.1400
|
-
|
Announcement Date
|
14/08/20
|
14/08/20
|
13/04/21
|
01/04/22
|
20/04/23
|
22/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
132
|
171
|
846
|
625
|
242
|
91.9
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
10.5
|
33.8
|
5.74
|
-123
|
-68.7
|
-106
|
ROE (net income / shareholders' equity)
|
17%
|
17.5%
|
10.4%
|
6.33%
|
2.41%
|
1.71%
|
ROA (Net income/ Total Assets)
|
9.97%
|
10.3%
|
5.32%
|
2.77%
|
1.03%
|
0.9%
|
Assets
1 |
616.7
|
720
|
1,593
|
2,885
|
4,143
|
4,437
|
Book Value Per Share
2 |
5.540
|
6.330
|
12.50
|
12.90
|
13.20
|
13.50
|
Cash Flow per Share
2 |
1.070
|
1.220
|
6.810
|
2.330
|
0.9700
|
0.7200
|
Capex
1 |
43.9
|
35.5
|
62.4
|
143
|
72.2
|
37.7
|
Capex / Sales
|
14.34%
|
10.01%
|
16.63%
|
32.65%
|
14.22%
|
7.59%
|
Announcement Date
|
14/08/20
|
14/08/20
|
13/04/21
|
01/04/22
|
20/04/23
|
22/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -27.15% | 233M | | -1.52% | 8.37B | | +10.68% | 5.84B | | +26.94% | 5.4B | | -5.09% | 4.37B | | -52.54% | 3.23B | | +14.18% | 2.8B | | +32.50% | 2.26B | | -6.47% | 2.22B | | -1.69% | 1.87B |
Diagnostic & Testing Substances
|